The Searle Company Limited (KASE: SEARL)
Health Care · Pharmaceuticals · PK
PKRs87.67
-2.79% today · -10.4% 1Y
The Searle Company Limited (KASE: SEARL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $185.92M.
Over the last twelve months the share price has lost 10.4%, trading between 76.37 and 137.44.
Tweenvest scores The Searle Company Limited across four factors: quality 65/100, value 42/100, growth 0/100. Its strongest factor is quality.
SEARL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $185.92M
- Revenue (TTM)
- $129.02M
- P/E
- 23.92
- EPS
- 2.06
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- PKRs137.44
- 52-week low
- PKRs76.37
- Avg volume (3M)
- —
- Shares outstanding
- 588.22M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.36 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.50 | +0.13% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.